JNJ - JOHNSON & JOHNSON
166.69
0.860 0.516%
Share volume: 9,637,593
Last Updated: 03-07-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$165.83
0.86
0.01%
Summary score
55%
Profitability
63%
Dept financing
36%
Liquidity
71%
Performance
46%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
8.16%
Return on assets
2.99%
Return on sales
25.12%
Return on invested capital
8.17%
Total debt ratio
59.66%
Debt ratio change over timeo
-27.85%
Current Ratio
1.2%
Quick Ratio
0.96%
Cash Position Ratio
0.54%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
5.6%
Return on assets
2.69%
Return on sales
25.18%
Return on invested capital
5.84%
Total debt ratio
60.09%
Debt ratio change over timeo
9.02%
Current Ratio
1.1%
Quick Ratio
0.87%
Cash Position Ratio
0.48%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
2.08%
Return on sales
15.91%
Return on invested capital
0%
Total debt ratio
60.31%
Debt ratio change over time
0%
Current Ratio
1.11%
Quick Ratio
0.86%
Cash Position Ratio
0.48%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
3.21%
Return on assets
-245.45%
Return on sales
-1223.31%
Return on invested capital
1.56%
Total debt ratio
-2785.36%
Debt ratio change over time
-27.85%
Current Ratio
-42.95%
Quick Ratio
-34.56%
Cash Position Ratio
-15.8%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | JNJ | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 8.16% | 15.71% | 0% | 0% |
| Return on assets | 2.99% | 4.24% | 0% | 0% |
| Return on sales | 25.12% | 28.08% | 0% | 0% |
| Return on invested capital | 8.17% | 9.78% | 0% | 0% |
| Profitability | 74% | 100% | 0% | 0% |
| Total debt ratio | 59.66% | 81.31% | 0% | 0% |
| Debt ratio change over time | -27.85% | -15.58% | 0% | 0% |
| Dept financing | 18% | 25% | 25% | 0% |
| Current Ratio | 1.1% | 1.25% | 0% | 0% |
| Quick Ratio | 0.87% | 0.96% | 0% | 0% |
| Cash Position Ratio | 0.48% | 0.13% | 0% | 0% |
| Liquididy | 75% | 56% | 0% | 0% |
| Short-term ratios | JNJ | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 5.6% | 17.51% | 0% | 0% |
| Return on assets | 2.69% | 4.29% | 0% | 0% |
| Return on sales | 25.18% | 28.55% | 0% | 0% |
| Return on invested capital | 5.84% | 11.13% | 0% | 0% |
| Profitability | 59% | 100% | 0% | 0% |
| Total debt ratio | 60.09% | 80.84% | 0% | 0% |
| Debt ratio change over time | 9.02% | 4.11% | 0% | 0% |
| Dept financing | 44% | 36% | 0% | 0% |
| Current Ratio | 1.1% | 1.25% | 0% | 0% |
| Quick Ratio | 0.87% | 0.96% | 0% | 0% |
| Cash Position Ratio | 0.48% | 0.13% | 0% | 0% |
| Liquididy | 70% | 57% | 0% | 0% |